Literature DB >> 20813137

Ligand-induced changes in hepatitis C virus NS5B polymerase structure.

Karen Rigat1, Yi Wang, Thomas W Hudyma, Min Ding, Xiaofan Zheng, Robert G Gentles, Brett R Beno, Min Gao, Susan B Roberts.   

Abstract

Hepatitis C virus (HCV) RNA-dependent RNA polymerase (NS5B) is required for viral replication. Crystal structures of the NS5B apoprotein show that the finger and thumb domains interact to encircle the active site, and that inhibitors defined by P495 resistance that bind to the thumb-finger interface displace the Δ1 finger loop and disrupt this structure. Since crystal structures may not reveal all of the conformations of a protein in solution we have developed an alternative method, using limited trypsin protease digestion, to investigate the impact of inhibitors as well as substrates on the movement of the Δ1 loop. This assay can be used to study NS5B under conditions that support enzymatic activity. In the absence of inhibitors, no specific region of NS5B was hypersensitive to trypsin, and no specific intermediate cleavage products were formed. Binding of P495-site inhibitors to NS5B induced specific trypsin hypersensitivity at lysine residues 50 and 51. Previously characterized inhibitors and mutant polymerases were used to link this specific trypsin hypersensitivity to movement of the Δ1 loop. Trypsin hypersensitivity identical to the inhibitor pattern was also induced by the binding of the RNA template. The addition of primer to the NS5B-template complex eliminated the hypersensitivity. The data are consistent with displacement of the Δ1 finger loop from the thumb by the binding of template, and reversal by the addition of primer or NTP. Our results complement inhibitor-enzyme co-crystal studies, and the assay provides a rapid and sensitive method to study dynamic changes in HCV NS5B polymerase conformation under conditions that support functional activity.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813137     DOI: 10.1016/j.antiviral.2010.08.014

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  11 in total

1.  Identification and functional characterization of the nascent RNA contacting residues of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Robert Vaughan; Baochang Fan; Jin-Sam You; C Cheng Kao
Journal:  RNA       Date:  2012-06-26       Impact factor: 4.942

2.  Potency and resistance analysis of hepatitis C virus NS5B polymerase inhibitor BMS-791325 on all major genotypes.

Authors:  Mengping Liu; Maria Tuttle; Min Gao; Julie A Lemm
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

3.  Synergistic Activity of Combined NS5A Inhibitors.

Authors:  Donald R O'Boyle; Peter T Nower; Min Gao; Robert Fridell; Chunfu Wang; Piyasena Hewawasam; Omar Lopez; Yong Tu; Nicholas A Meanwell; Makonen Belema; Susan B Roberts; Mark Cockett; Jin-Hua Sun
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

4.  Initiation of RNA synthesis by the hepatitis C virus RNA-dependent RNA polymerase is affected by the structure of the RNA template.

Authors:  Stefan Reich; Michael Kovermann; Hauke Lilie; Paul Knick; René Geissler; Ralph Peter Golbik; Jochen Balbach; Sven-Erik Behrens
Journal:  Biochemistry       Date:  2014-10-31       Impact factor: 3.162

5.  Hepatitis C virus NS5B and host cyclophilin A share a common binding site on NS5A.

Authors:  Claire Rosnoblet; Bernd Fritzinger; Dominique Legrand; Hélène Launay; Jean-Michel Wieruszeski; Guy Lippens; Xavier Hanoulle
Journal:  J Biol Chem       Date:  2012-11-14       Impact factor: 5.157

6.  Inhibitors for the hepatitis C virus RNA polymerase explored by SAR with advanced machine learning methods.

Authors:  Iwona E Weidlich; Igor V Filippov; Jodian Brown; Neerja Kaushik-Basu; Ramalingam Krishnan; Marc C Nicklaus; Ian F Thorpe
Journal:  Bioorg Med Chem       Date:  2013-03-29       Impact factor: 3.641

7.  Mechanism of inhibition for BMS-791325, a novel non-nucleoside inhibitor of hepatitis C virus NS5B polymerase.

Authors:  Karen L Rigat; Hao Lu; Ying-Kai Wang; Argyrides Argyrou; Caroline Fanslau; Brett Beno; Yi Wang; Jovita Marcinkeviciene; Min Ding; Robert G Gentles; Min Gao; Lynn M Abell; Susan B Roberts
Journal:  J Biol Chem       Date:  2014-10-09       Impact factor: 5.157

8.  Hydrogen/Deuterium Exchange Kinetics Demonstrate Long Range Allosteric Effects of Thumb Site 2 Inhibitors of Hepatitis C Viral RNA-dependent RNA Polymerase.

Authors:  Daniel Deredge; Jiawen Li; Kenneth A Johnson; Patrick L Wintrode
Journal:  J Biol Chem       Date:  2016-03-22       Impact factor: 5.486

9.  NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B.

Authors:  Luiza M Bessa; Hélène Launay; Marie Dujardin; François-Xavier Cantrelle; Guy Lippens; Isabelle Landrieu; Robert Schneider; Xavier Hanoulle
Journal:  J Biol Chem       Date:  2017-09-14       Impact factor: 5.486

10.  Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C Virus NS5B polymerase.

Authors:  Julie A Lemm; Mengping Liu; Robert G Gentles; Min Ding; Stacey Voss; Lenore A Pelosi; Ying-Kai Wang; Karen L Rigat; Kathleen W Mosure; John A Bender; Jay O Knipe; Richard Colonno; Nicholas A Meanwell; John F Kadow; Kenneth S Santone; Susan B Roberts; Min Gao
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.